As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination coverage increases in the United States, there is a need to understand the real-world effectiveness against severe coronavirus disease 2019 (COVID-19) and among people at increased risk for poor outcomes.
December 18, 2023CU Anschutz
Leprino Building
12401 East 17th Avenue
7th Floor
Aurora, CO 80045